Augmedix, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Augmedix, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2019 to Q1 2024.
  • Augmedix, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $59K, a 98.8% decline year-over-year.
  • Augmedix, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $43.4M.
  • Augmedix, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$1.24M, a 103% decline from 2021.
  • Augmedix, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $37.8M, a 43.2% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $59K -$5.03M -98.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q1 2023 $5.09M +$5.07M +39015% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q1 2022 $13K -$1.81M -99.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q1 2021 $1.82M +$1.32M +266% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q1 2020 $498K +$487K +4414% Jan 1, 2020 Mar 31, 2020 10-Q/A 2021-06-30
Q1 2019 $11K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.